HDAC2 and neoplasm: While this suggests that HDAC2 is a novel molecular marker and gatekeeper for apoptosis resistance to 5-FU, additional data are needed to test whether a lack of HDAC2 in significant parts of tumor mass can explain why subsets of MSI are not successfully treated with 5-FU (Vilar and Gruber 2010).